Human medicinal products
SPC PL
Veterinary medicinal
products
SPC PL
Herbal medicinal products
SPC PL
Name of the medicinal
product
A B C D E F G
H I J K L M N
O P Q R S T U
V W X Y Z Å Ä Ö
Name of the medicinal
product

Marketing authorisation
holder

Marketing authorisation
number

ATC Code Codes

Free text search

Active agent

Pharmaceutical form

Adverse effect

Therapeutic indication

Contraindication

Insert text in the fields in Finnish


Summaries of Product Characteristics (SPC) for Human medicinal products

The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.

Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.

The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.

The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.


Summaries of Product Characteristics 121 - 150 of 378
Previous 30    |  1  2  3  4  5  6  7  8  9  10  11  12  13  |  Next 30   >    
Package
leaflet
Status for
supply
Name of the medicinal product

European Medicines Agency's website:
Catiolanze - EMA: EPAR PI
Finnish Swedish

PL

Resepti

Caverject Dual 10 mikrog, 20 mikrog injektiokuiva-aine ja liuotin SPC 2020-02-03

European Medicines Agency's website:
Cayston - EMA: EPAR PI
Finnish Swedish

PL

Resepti

Cefazolin MIP Pharma 2 g injektio-infuusiokuiva-aine, liuosta varten SPC 2021-11-17

PL

Resepti

Cefepim MIP Pharma 1 g, 2 g injektio-infuusiokuiva-aine, liuosta varten SPC 2021-11-10

PL

Resepti

Cefotaxim MIP Pharma 1 g, 2 g injektio-infuusiokuiva-aine liuosta varten SPC 2024-02-29

PL

Resepti

Ceftazidim Fresenius Kabi 1000 mg injektiokuiva-aine, 2000 mg injektio-infuusiokuiva-aine liuosta varten SPC 2023-11-17

PL

Resepti

Ceftazidim MIP Pharma 1 g, 2 g injektio-infuusiokuiva-aine liuosta varten SPC 2022-01-04

PL

Resepti

Ceftriaxon Copyfarm 1g injektiokuiva-aine ja 2g infuusiokuiva-aine SPC 2010-01-06

PL

Resepti

Ceftriaxon Fresenius Kabi 1 g injektio-infuusiokuiva-aine, liuosta varten SPC 2024-04-29

PL

Resepti

Ceftriaxon Fresenius Kabi 2 g infuusiokuiva-aine, liuosta varten SPC 2024-04-29

PL

Resepti

Ceftriaxon MIP Pharma 1 g injektio-infuusiokuiva-aine liuosta varten, 2 g infuusiokuiva-aine, liuosta varten SPC 2024-04-02

PL

Resepti

Ceftriaxon Navamedic 1 g injektio-infuusiokuiva-aine liuosta varten, 2 g infuusiokuiva-aine, liuosta varten SPC 2024-07-05

PL

Resepti

Ceftriaxone Kalceks 1 g, 2 g injektio-infuusiokuiva-aine, liuosta varten SPC 2024-05-01

PL

Resepti

Cefuroxim MIP Pharma 750 mg, 1500 mg injektio-infuusiokuiva-aine liuosta varten SPC 2023-05-25

PL

Resepti

Cefuroxim Navamedic 250 mg, 750 mg, 1500 mg injektio-/infuusiokuiva-aine liuosta varten SPC 2024-07-01

PL

Resepti

Cefuroxime Kalceks 750 mg, 1500 mg injektio-infuusiokuiva-aine liuosta varten SPC 2023-10-10

PL

Resepti

Cefuroxime Orion Pharma 750 mg, 1.5 g injektio-infuusiokuiva-aine, liuosta-suspensiota varten SPC 2023-01-26

European Medicines Agency's website:
Cegfila - EMA: EPAR PI
Finnish Swedish

European Medicines Agency's website:
Cejemly - EMA: EPAR PI
Finnish Swedish

European Medicines Agency's website:
Celdoxome pegylated liposomal - EMA: EPAR PI
Finnish Swedish

PL

Resepti

Celebra 100 mg, 200 mg kapseli, kova SPC 2022-02-09

PL

Resepti

Celecoxib Krka 100 mg, 200 mg kapseli, kova SPC 2024-05-13

PL

Resepti

Celecoxib Stada 100 mg, 200 mg kapseli, kova SPC 2021-05-06

PL

Resepti

Celecoxib Viatris 100 mg, 200 mg kapseli, kova SPC 2022-06-10

PL

Resepti

Celeston Chronodose 3+3 mg-ml injektioneste, suspensio SPC 2021-10-11

PL

Resepti

Celiprolol Vitabalans 200 mg, 400 mg tabletti, kalvopäällysteinen SPC 2021-03-17

European Medicines Agency's website:
CellCept - EMA: EPAR PI
Finnish Swedish

European Medicines Agency's website:
Celldemic - EMA: EPAR PI
Finnish Swedish

PL

Itsehoito

Celluvisc 1.0 % silmätipat, liuos, kerta-annospakkaus SPC 2022-03-16

Previous 30    |  1  2  3  4  5  6  7  8  9  10  11  12  13  |  Next 30   >